Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RANGE: gefitinib versus platinum-based chemotherapy in EGFR FISH-positive advanced non-small cell lung cancer
2008-002018-23Phase 3Terminated
- Sponsor
- Humanitas Research Hospital
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of gefitinib in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Humanitas Research Hospital. Primary endpoint: Improvement in patient reported functionality. Started Nov 2008; status: terminated.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2008-002018-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002018-23.